Creso Pharma Limited Stock Current Ratio
| COPHFDelisted Stock | USD 0.12 0.00 0.00% |
Creso Pharma Limited fundamentals help investors to digest information that contributes to Creso Pharma's financial success or failures. It also enables traders to predict the movement of Creso Pink Sheet. The fundamental analysis module provides a way to measure Creso Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Creso Pharma pink sheet.
Creso |
Creso Pharma Limited Company Current Ratio Analysis
Creso Pharma's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Creso Pharma Current Ratio | 2.68 X |
Most of Creso Pharma's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Creso Pharma Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Creso Pharma Limited has a Current Ratio of 2.68 times. This is 7.9% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current ratio for all United States stocks is 24.07% lower than that of the firm.
Creso Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Creso Pharma's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Creso Pharma could also be used in its relative valuation, which is a method of valuing Creso Pharma by comparing valuation metrics of similar companies.Creso Pharma is currently under evaluation in current ratio category among its peers.
Creso Fundamentals
| Return On Equity | -0.67 | |||
| Return On Asset | -0.38 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (2.39) % | |||
| Current Valuation | 24.06 M | |||
| Shares Outstanding | 2 B | |||
| Shares Owned By Insiders | 26.99 % | |||
| Price To Book | 0.36 X | |||
| Price To Sales | 4.68 X | |||
| Revenue | 6.22 M | |||
| Gross Profit | (400.39 K) | |||
| EBITDA | (28.06 M) | |||
| Net Income | (30.03 M) | |||
| Cash And Equivalents | 3.14 M | |||
| Total Debt | 3.26 M | |||
| Debt To Equity | 0.24 % | |||
| Current Ratio | 2.68 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (22.38 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 19 | |||
| Beta | 2.61 | |||
| Market Capitalization | 49.92 M | |||
| Total Asset | 29.31 M | |||
| Z Score | 9.0 | |||
| Net Asset | 29.31 M |
About Creso Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Creso Pharma Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Creso Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Creso Pharma Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Creso Pink Sheet
If you are still planning to invest in Creso Pharma Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Creso Pharma's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |